Payment Secured by 128/256 SSL Encryption
Download App
Neurological disorder, It is used to treat conditions such as epilepsy and bipolar disorder.
Encorate 300mg
Use Code - NEW70 to get flat Rs.70/- Off on orders above 699/-.
Rx Prescription Required
Salt Composition sodium valproate300 mg
Therapeutic Class Central Nervous System
Manufacture Sun Pharmaceutical Industries Ltd.
Pack Size 10 Tablet
₹44.35
Gold Card
₹ 43.35
Unlock
Get Upto 30% Off On Medicines with Prepay offers.
24 Hours Express Delivery
| Weight | 0.1 kg |
|---|---|
| Pack Size | 10 |
| Pack Form | Tablet |
| Country of origin | india |
Increased risk of hepatotoxicity in childn <2 yr, congenital metabolic disorders, organic brain disease or severe seizure disorders. HIV or cytomegalovirus (CMV) infection; SLE. Decrease dose or discontinue in patients w/ excessive somnolence, decreased food or fluid intake. Gradual withdrawal or transition to and from another type of antiepileptic therapy. Suspect hyperammonemic encephalopathy and measure ammonia levels in patients who develop unexplained lethargy, vomiting or changes in mental status. Immobilised patients or those who have insufficient sun exposure or calcium intake should consider vitamin supplementation. Decrease GI side effects by taking w/ meals, starting w/ low dose or taking the enteric coated formulations. Lactation. Patient Counselling Seek medical advice during first signs of pancreatitis (e.g. abdominal pain, nausea, vomiting and anorexia), blood and liver toxicity. Monitoring Parameters Monitor LFT before and during the 1st 6 mth of therapy. Monitor blood cell count (including platelet count), bleeding time and coagulation tests before the start of therapy or before surgery, and in cases of spontaneous bruising or bleeding. Monitor for atypical behaviour (e.g. suicidal ideation and behaviour) during and after therapy., Please consult with the physician during pregnancy and lactation.
Headache, nausea, vomiting, diarrhoea, anorexia, increased appetite, wt gain, nystagmus, somnolence, dizziness, fatigue, hyperammonaemic encephalopathy, hypothermia, hallucinations. Thrombocytopenia (dose related), tremors, LFT elevation. Chronic use may lead to carnitine deficiency.
Preexisting or family history of hepatic dysfunction, active liver disease, porphyria; mitochondrial and urea cycle disorders. Hepatic impairment. Pregnancy.
